Is Lam Research Stock Built to Withstand More Downside?

LRCX: Lam Research logo
LRCX
Lam Research

Lam Research (LRCX) stock is down 6.1% in a day. The recent slide reflects geopolitical risks, broader market woes, and insider sales, but sharp drops like this often raise a tougher question: Is the weakness temporary or a sign of deeper cracks in the story?

Before judging its downturn resilience, let’s look at where Lam Research stands today.

  • Size: Lam Research is a $272 Bil company with $21 Bil in revenue currently trading at $217.01.
  • Fundamentals: Last 12 months’ revenue growth of 26.8% and operating margin of 33.8%.
  • Liquidity: Has a Debt to Equity ratio of 0.02 and Cash to Assets ratio of 0.29
  • Valuation: Lam Research stock is currently trading at P/E multiple of 43.8 and P/EBIT multiple of 37.9
  • Has returned (median) 238% within a year following sharp dips since 2010. See LRCX Dip Buy Analysis.

These metrics point to a Very Strong operational performance, alongside a very high valuation—making the stock Attractive but volatile. For details, see Buy or Sell LRCX Stock

That brings us to the key consideration for investors worried about this fall: how resilient is LRCX stock if markets turn south? This is where our downturn resilience framework comes in. Suppose LRCX stock falls another 20-30% to $152 – can investors comfortably hold on? Turns out, the stock has fared worse than the S&P 500 index during various economic downturns, based on (a) how much the stock fell and, (b) how quickly it recovered. Below, we dive deeper into each such downturn.

Relevant Articles
  1. Microsoft Stock: Is The 15% Drop A Buying Opportunity Or A Warning Sign?
  2. Adobe Stock Sell-Off: What Happened And Does It Matter?
  3. What’s Happening With Block Stock?
  4. When Oil Moves, Bitcoin Bleeds
  5. This Strategy Pays You 12% While Lining Up PYPL at Bargain Prices
  6. The Next Big Rally in Microsoft Stock Could Start Like This

Trefis: LRCX Stock Insights

2022 Inflation Shock

  • LRCX stock fell 56.8% from a high of $72.98 on 14 January 2022 to $31.50 on 14 October 2022 vs. a peak-to-trough decline of 25.4% for the S&P 500.
  • However, the stock fully recovered to its pre-Crisis peak by 11 December 2023
  • Since then, the stock increased to a high of $249.48 on 25 February 2026 , and currently trades at $217.01

 

LRCX S&P 500
% Change from Pre-Recession Peak -56.8% -25.4%
Time to Full Recovery 423 days 464 days

2020 Covid Pandemic

  • LRCX stock fell 45.0% from a high of $34.16 on 13 February 2020 to $18.79 on 20 March 2020 vs. a peak-to-trough decline of 33.9% for the S&P 500.
  • However, the stock fully recovered to its pre-Crisis peak by 14 July 2020

 

LRCX S&P 500
% Change from Pre-Recession Peak -45.0% -33.9%
Time to Full Recovery 116 days 148 days

2018 Correction

  • LRCX stock fell 46.1% from a high of $22.87 on 12 March 2018 to $12.33 on 24 December 2018 vs. a peak-to-trough decline of 19.8% for the S&P 500.
  • However, the stock fully recovered to its pre-Crisis peak by 9 September 2019

 

LRCX S&P 500
% Change from Pre-Recession Peak -46.1% -19.8%
Time to Full Recovery 259 days 120 days

2008 Global Financial Crisis

  • LRCX stock fell 75.0% from a high of $6.00 on 17 July 2007 to $1.50 on 19 November 2008 vs. a peak-to-trough decline of 56.8% for the S&P 500.
  • However, the stock fully recovered to its pre-Crisis peak by 23 May 2014

 

LRCX S&P 500
% Change from Pre-Recession Peak -75.0% -56.8%
Time to Full Recovery 2,011 days 1,480 days

Feeling jittery about LRCX stock? Consider a portfolio approach.

The Right Way To Invest Is Through Portfolios

Single stocks swing wildly, but staying invested matters. A well-built portfolio helps you stay invested, captures upside, and softens the blows from individual stocks.

Beating the market consistently is hard, but the Trefis High Quality (HQ) Portfolio makes it look achievable. By selecting 30 high-conviction stocks, the HQ strategy has historically outpaced the S&P 500, S&P Mid-cap, and Russell 2000. See how this curated selection delivers superior risk-adjusted returns in our detailed performance factsheet.